Fairly disappointed with this announcement but this strategic...

Fairly disappointed with this announcement but this strategic review was needed with macro environment and declining spodumene prices. This is another short term blip, but in difficult environment like this we need to make hard decision. Gareth has made this call, timing is never great but here is my take.
1. Revenue: No change to base operation at Grants, we will continue to process ore and make spodumene with ROM stockpile during wet season. Using last quarterly we may produce 30,000t of concentrate Jan-Mar 2024.
2. Capex: Reduction on development expenditures. BP33 early works are suspended, IMO these works were accelerated in the last 6 months. All work during Christmas / NY are suspended anyway due to holiday season. I see this as temporary maybe 1-3 months until Chinese New Year where an uptick in prices are expected.
3. Capex: Reduction in Exploration expenditure, this is key we need to preserve cash short term to add business value long term. We have Grants 4 years and BP33 10 years so drilling activity can wait for another year.
4. Opex: As mentioned by a few holders there were redundancies at Core, I hope Gareth is working on reducing all discretionary / operating cost. This is where Gareth and the Management team need to show responsibility and take significant pay cut. Show some skin in the game!
5. Funding: I know we had a major capital raising $100M in the last quarter. IMO there is reference to Commercial Solution, in the unlikely event I hope Gareth considers all options (NAIF, Govt grant / sponsor / loan etc) without any further Shareholder dilution.

This is back to bottom drawer for a few months. With all the EV news, Lithium prices will not stay at this level IMO.
I wish all holders safe and Merry Christmas.